Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bradly D. Clark"'
Autor:
Dilip Giri, Barbara Susnik, Kristen Polo, Andrea V. Barrio, Stephanie F. Bernik, Bradly D. Clark, Sujata Patil, Kimberly J. Van Zee, Laurie W. Flynn, Jessica Goldberg, Laura Weldon Hoque
Publikováno v:
Annals of Surgical Oncology. 14:2961-2970
Phyllodes tumors (PT) are rare fibroepithelial neoplasms of the breast with unpredictable behavior. We reviewed our single institution experience with PT over 51 years to identify factors predictive of local recurrence (LR) and metastasis. From 1954
Publikováno v:
Blood. 107:3489-3491
Investigators in the United Kingdom have shown that hereditary amyloidosis can be misdiagnosed as Ig light-chain (AL) amyloidosis because family history is an ineffective screen, and tissue staining used to type amyloid is unreliable. Misdiagnosis of
Autor:
Roger S. Riley, Shawn Zhao, Jonathan Ben-Ezra, Micaela Ross, Bradly D. Clark, Alden Chesney, David C. Williams
Publikováno v:
Journal of clinical laboratory analysis. 23(5)
Bone marrow examination has become increasingly important for the diagnosis and treatment of hematologic and other illnesses. Morphologic evaluation of the bone marrow aspirate and biopsy has recently been supplemented by increasingly sophisticated a
Autor:
Boaz Hirshberg, Bradly D. Clark, P. Michael Conn, Lynnette K. Nieman, Gabriel I. Uwaifo, Keith L. Blauer
Publikováno v:
The New England journal of medicine. 348(4)
A 40-year-old woman referred for evaluation of markedly elevated levels of luteinizing hormone — identified in the course of an infertility workup — is the subject of this Brief Report. Investigation showed ectopic secretion of luteinizing hormon
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 15(12)
Bronchoalveolar lavage (BAL) and lung fine-needle aspirate (LFNA) are commonly performed as the first line of investigation for a myriad of pulmonary problems associated with abnormal imaging findings (mass, cavitary lesion, infiltrates, etc.). The r
Autor:
Lilian Reich, Xiaoshe Chen, Nancy H. Collins, Stephen D. Nimer, Bradly D. Clark, Martin Fleisher, Hani Hassoun, Julie Teruya-Feldstein, Ping Zhou, Raymond L. Comenzo, David Wuest, Andre Nuta
Publikováno v:
Blood. 108:3087-3087
Systemic light-chain (AL) amyloidosis is both a protein deposition disorder and a monoclonal plasma cell dyscrasia. Effective treatment depends on reduction of the clonal plasma cells that produce the toxic light chains. Although high-dose melphalan
Autor:
Raymond L. Comenzo, Bradly D. Clark, Cristina R. Antonescu, Ping Zhou, Martin Fleisher, Andre L. Moreira, Hani Hassoun, Oscar Lin, Julie Teruya-Feldstein
Publikováno v:
Blood. 106:5107-5107
Background: The diagnosis of amyloidosis is relevant in patients with monoclonal gammopathies (MG) and unexplained organ dysfunction, or in those with peripheral neuropathy or a family history of amyloidosis. Tissue diagnosis is essential to clinical
Autor:
Ping Zhou, Julie Teruya-Feldstein, Limin Wang, Raymond L. Comenzo, Bradly D. Clark, Martin Fleisher
Publikováno v:
Blood. 106:5099-5099
In order to treat patients with symptomatic amyloidosis, the amyloidosis must be typed with confidence. Immunohistochemical techniques for light-chain isotype identification of amyloid are not reliable, and techniques to type fibrils extracted from c